MEDP Medpace
Medpace earnings company data as of 4:47 AM ET 9/25
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 28 Oct | EPS | 4.45 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by MEDP's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $454M sold by 9 insiders outside a trading plan
- $12.8M sold by 1 insider under 10b5-1 plans
-
August J. Troendle CEOSale$30.3M 48,667 shares at $623.03 13% of stakeTraded Sep 29–30 Filed Oct 1
-
August J. Troendle CEOSale$1.6M 2,564 shares at $620.10 0.7% of stakeTraded Sep 25–28 Filed Sep 29
-
August J. Troendle CEOSale$27.4M 43,916 shares at $624.01 10% of stakeTraded Sep 23–24 Filed Sep 25
-
August J. Troendle CEOSale$44.4M 70,901 shares at $626.62 14% of stakeTraded Sep 21–22 Filed Sep 23
-
August J. Troendle CEOSale$6.7M 10,880 shares at $620.40 2.1% of stakeTraded Sep 17 Filed Sep 21
-
August J. Troendle CEOSale$15.4M 24,741 shares at $621.00 4.6% of stakeTraded Sep 15–16 Filed Sep 17
-
August J. Troendle CEOSale$403K 650 shares at $620.27 0.1% of stakeTraded Aug 27 Filed Aug 31
-
Robert O. Kraft DirectorSale$2.4M 3,858 shares at $617.81 80% of stakeTraded Aug 26 Filed Aug 28
-
August J. Troendle CEOSale$2.9M 4,673 shares at $620.08 0.9% of stakeTraded Aug 25–26 Filed Aug 27
-
August J. Troendle CEOSale$10M 15,978 shares at $623.93 2.8% of stakeTraded Aug 21–24 Filed Aug 25
-
Kevin M. Brady CFOSale$2.1M 3,400 shares at $625.24 21% of stakeTraded Aug 20 Filed Aug 24
-
August J. Troendle CEOSale$26.3M 42,783 shares at $614.30 7.1% of stakeTraded Aug 19–20 Filed Aug 21
-
Brian T Carley DirectorSale$3M 5,000 shares at $608.63 15% of stakeTraded Aug 19 Filed Aug 21
-
Fred B Davenport Jr. DirectorSale$4.4M 7,283 shares at $606.15 66% of stakeTraded Aug 19 Filed Aug 21
-
August J. Troendle CEOSale$7.1M 11,824 shares at $601.49 1.9% of stakeTraded Aug 12–13 Filed Aug 14
Also filed in the last 12 months, not counted as buying or selling: 37 option exercises and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 8 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.